ÂÜÀòÂÒÂ×

Paul Bikard is currently serving as the Chief Financial Officer at Accure Therapeutics and as a Board Member at Medevise. With a background in financial consulting and executive roles in various biotech companies, including Mampa CF, SENSORION, Prestwick Chemical, and Transgene, Paul brings a wealth of experience in the industry. Paul also held managerial positions at Arthur Andersen and Price Waterhouse Coopers earlier in their career. Paul holds a degree from emlyon business school and Collège Kennedy Mulhouse.